In the news release, Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency, issued 29-May-2023 by Amplo Biotechnology over PR ...
Amplo Biotechnology Inc. has been awarded a fast track phase I/II Small Business Technology Transfer (STTR) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results